These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30356433)

  • 1. Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE).
    Straubel D; Thielitz A; Reinhold A; Grüngreiff K; Reinhold D
    J Immunol Res; 2018; 2018():5982169. PubMed ID: 30356433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc aspartate suppresses T cell activation in vitro and relapsing experimental autoimmune encephalomyelitis in SJL/J mice.
    Stoye D; Schubert C; Goihl A; Guttek K; Reinhold A; Brocke S; Grüngreiff K; Reinhold D
    Biometals; 2012 Jun; 25(3):529-39. PubMed ID: 22350510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral zinc aspartate treats experimental autoimmune encephalomyelitis.
    Schubert C; Guttek K; Grüngreiff K; Thielitz A; Bühling F; Reinhold A; Brocke S; Reinhold D
    Biometals; 2014 Dec; 27(6):1249-62. PubMed ID: 25146336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Humle Jorgensen S; Sorensen PS
    J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
    J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action.
    Achiron A; Gilad R; Margalit R; Gabbay U; Sarova-Pinhas I; Cohen IR; Melamed E; Lider O; Noy S; Ziv I
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):57-61. PubMed ID: 7964856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151.
    Zhang B; Harness J; Somodevilla-Torres MJ; Hillyard NC; Mould AW; Alewood D; Love SG; Alewood PF; Greer JM; Cavanagh AC; McCombe PA; Morton H
    J Neurol Sci; 2000 Dec; 182(1):5-15. PubMed ID: 11102634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
    Wegmann KW; Archie Bouwer HG; Whitham RH; Hinrichs DJ
    J Neuroimmunol; 2014 Sep; 274(1-2):46-52. PubMed ID: 24997489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
    Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y
    Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.
    Oxombre B; Lee-Chang C; Duhamel A; Toussaint M; Giroux M; Donnier-Maréchal M; Carato P; Lefranc D; Zéphir H; Prin L; Melnyk P; Vermersch P
    Br J Pharmacol; 2015 Apr; 172(7):1769-82. PubMed ID: 25521311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
    Mondal S; Pahan K
    PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE.
    Offner H; Zamora A; Drought H; Matejuk A; Auci DL; Morgan EE; Vandenbark AA; Reading CL
    J Neuroimmunol; 2002 Sep; 130(1-2):128-39. PubMed ID: 12225895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin ameliorates experimental autoimmune encephalomyelitis and reduces neuropathological abnormalities when administered prophylactically.
    Jorgensen SH; Jensen PE; Laursen H; Sorensen PS
    Neurol Res; 2005 Sep; 27(6):591-7. PubMed ID: 16157008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
    Soelberg Sorensen P
    Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
    Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
    Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
    Aharoni R; Eilam R; Stock A; Vainshtein A; Shezen E; Gal H; Friedman N; Arnon R
    J Neuroimmunol; 2010 Aug; 225(1-2):100-11. PubMed ID: 20554028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
    Touil T; Ciric B; Ventura E; Shindler KS; Gran B; Rostami A
    J Neurol Sci; 2008 Aug; 271(1-2):191-202. PubMed ID: 18544456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.